TETRAPHASE PHARMACEUTICALS INC 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Mar 14, 2014
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2014-03-12+4,493→ 4,493 total(indirect: By LLC) - Other
Common Stock
2014-03-12−300,000→ 1,890,146 total(indirect: See footnote)
Footnotes (2)
- [F1]Represents a pro-rata in-kind distribution by Skyline Venture Partners Qualified Purchaser Fund IV, L.P. ("SVP IV") without consideration to its limited and general partners.
- [F2]The shares are held by SVP IV. John G. Freund, M.D. and Yasunori Kaneko, M.D. are the Managing Members of Skyline Venture Management IV, LLC, the general partner of SVP IV, and may be deemed to share voting and dispositive power over the shares held by SVP IV. Stephen Hoffman, M.D., Ph.D. is a member of Skyline Venture Management IV, LLC and may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by SVP IV. Each of Dr. Freund and Mr. Hoffman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Dr. Freund is a director of the Issuer and, accordingly, files separate Section 16 reports.